Currently out of the existing stock ratings of David Macdonald, 233 are a HOLD (44.55%), 287 are a BUY (54.88%), 3 are a SELL (0.57%).

David Macdonald

Work Performance Price Targets & Ratings Chart

Analyst David Macdonald, currently employed at TRUIST, carries an average stock price target met ratio of 64.23% that have a potential upside of 20.2% achieved within 205 days.

David Macdonald’s has documented 1,018 price targets and ratings displayed on 34 stocks. The coverage is on Healthcare, Consumer Defensive sectors.

Most recent stock forecast was given on CNC, Centene Corp at 12-Sep-2025.

Wall Street Analyst David Macdonald

Analyst best performing recommendations are on GRDN (GUARDIAN PHARMACY SERVICES).
The best stock recommendation documented was for THC (TENET HEALTHCARE) at 4/3/2020. The price target of $18 was fulfilled within 5 days with a profit of $6.11 (51.39%) receiving and performance score of 102.78.

Average potential price target upside

of $87.28 (24.04%) on UNH (UNITEDHEALTH GROUP).
of $73.03 (22.68%) on ELV (ELEVANCE HEALTH).
of $70.64 (33.22%) on CI (CIGNA CORP).

AGL agilon health AHCO Adapthealth Corp AMED Amedisys ANTM Anthem AVAH Aveanna Healthcare Holdings CI Cigna Corp CNC Centene Corp CVS CVS Health Corp CYH Community Health Systems DGX Quest Diagnostics DVA DaVita HealthCare Partners EHC Encompass Health Corp ELV Elevance Health ENSG The Ensign Group FMS Fresenius Medical Care HCA HCA Holdings HUM Humana LH Laboratory of America Holdings LHCG LHC Group MD Mednax MOH Molina Healthcare ONE OneSmart International Education Group OSH Oak Street Health PNTG Pennant Group PRVA Privia Health Group THC Tenet Healthcare TVTY Tivity Health UNH UnitedHealth Group WBA Walgreens Boots Alliance OPCH Option Care Health RDNT RadNet ARDT Ardent Health Partners GRDN Guardian Pharmacy Services PACS PACS Group

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Bill Sutherland (BENCHMARK)